"Maximise the opportunity arising from Akorn’s bankruptcy"

  1. 62 Posts.
    lightbulb Created with Sketch. 24
    "On 23 February 2023, Akorn, Inc. announced it had entered Chapter VII bankruptcy and
    immediately ceased operations. At the time of this announcement Akorn was the market leader
    for prilocaine 2.5% and lidocaine 2.5% cream, holding market share exceeding 60%.

    Together Acrux and Padagis are working to maximise the opportunity arising from Akorn’s
    bankruptcy".


    Future dividends from this company will surprise the doubters.

    The current share price is unbelievably cheap.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $6.548M
Open High Low Value Volume
1.6¢ 1.6¢ 1.6¢ $2 103

Buyers (Bids)

No. Vol. Price($)
5 351893 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 358041 1
View Market Depth
Last trade - 14.28pm 11/08/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.